Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Mei Pharma Inc (MEIP)

Mei Pharma Inc (MEIP)
1.9800 +0.0700 (+3.66%) 13:46 ET [NASDAQ]
1.9700 x 3 2.0400 x 6
Realtime by (Cboe BZX)
1.9700 x 3 2.0400 x 6
Realtime - - (-) -
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.8600
Day High
1.9800
Open 1.9000
Previous Close 1.9100 1.9100
Volume 6,248 6,248
Avg Vol 11,534 11,534
Stochastic %K 60.88% 60.88%
Weighted Alpha -42.66 -42.66
5-Day Change +0.0700 (+3.66%) +0.0700 (+3.66%)
52-Week Range 1.4600 - 4.1000 1.4600 - 4.1000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,726
  • Shares Outstanding, K 6,663
  • Annual Sales, $ 65,300 K
  • Annual Income, $ 17,780 K
  • EBIT $ -34 M
  • EBITDA $ -22 M
  • 60-Month Beta 0.75
  • Price/Sales 0.20
  • Price/Cash Flow 0.33
  • Price/Book 0.59

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 45.34%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 905.70% on 03/26/25
  • IV Low 0.00% on 04/17/25
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 22
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 232
  • Open Int (30-Day) 277

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.37
  • Growth Rate Est. (year over year) +73,019.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4600 +35.62%
on 04/16/25
Period Open: 2.3000
2.3800 -16.81%
on 03/24/25
-0.3200 (-13.91%)
since 03/21/25
3-Month
1.4600 +35.62%
on 04/16/25
Period Open: 2.7700
2.9100 -31.96%
on 01/31/25
-0.7900 (-28.52%)
since 01/22/25
52-Week
1.4600 +35.62%
on 04/16/25
Period Open: 3.3700
4.1000 -51.71%
on 07/22/24
-1.3900 (-41.25%)
since 04/22/24

Most Recent Stories

More News
MEI Pharma Announces 1-for-20 Reverse Stock Split

MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that its board of directors approved a 1-for-20 reverse stock split....

MEIP : 1.9800 (+3.66%)
SHAREHOLDER ALERT: Weiss Law Investigates Infinity Pharmaceuticals, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Infinity...

INFI : 0.0080 (-50.00%)
MEIP : 1.9800 (+3.66%)
INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Infinity Pharmaceuticals, Inc. (the “Company”)...

INFI : 0.0080 (-50.00%)
MEIP : 1.9800 (+3.66%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Infinity Pharmaceuticals, Inc.

/PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and its board of...

INFI : 0.0080 (-50.00%)
MEIP : 1.9800 (+3.66%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNKB, PTRS, JNCE, MEIP

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PTRS : 7.15 (+0.99%)
JNCE : 1.8800 (-2.59%)
LNKB : 6.74 (+4.50%)
MEIP : 1.9800 (+3.66%)
MEIP STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of MEI Pharma, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of MEI Pharma, Inc. (NASDAQ: MEIP) and Infinity Pharmaceuticals, Inc. is fair to MEI shareholders. Per the merger agreement,...

MEIP : 1.9800 (+3.66%)
MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates

MEI Pharma, Inc. (Nasdaq: MEIP) (“MEI”), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, and Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”), a...

INFI : 0.0080 (-50.00%)
MEIP : 1.9800 (+3.66%)
MEI Pharma Reports Second Quarter Fiscal Year 2023 Results and Operational Highlights

MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for the quarter ended December 31, 2022, and highlighted recent...

MEIP : 1.9800 (+3.66%)
MEI Pharma Announces Adjournment of Annual Meeting of Stockholders

MEI Pharma, Inc. (Nasdaq: MEIP), a pharmaceutical company focused on advancing new therapies for cancer, announced today that its annual meeting of stockholders has been adjourned to January 5, 2023, at...

MEIP : 1.9800 (+3.66%)
MEI Pharma Initiates Strategic Realignment

MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that it plans to initiate a realignment of its clinical development...

MEIP : 1.9800 (+3.66%)

Business Summary

MEI Pharma, Inc. is an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism. The Company is focused on the clinical development of its two lead isoflavone-based drug candidates, ME-143 and ME-344. MEI Pharma, Inc., formerly known as Marshall Edwards,...

See More

Key Turning Points

3rd Resistance Point 2.0100
2nd Resistance Point 1.9900
1st Resistance Point 1.9500
Last Price 1.9800
1st Support Level 1.8900
2nd Support Level 1.8700
3rd Support Level 1.8300

See More

52-Week High 4.1000
Fibonacci 61.8% 3.0915
Fibonacci 50% 2.7800
Fibonacci 38.2% 2.4685
Last Price 1.9800
52-Week Low 1.4600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro